{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:26:30Z","timestamp":1792621590957,"version":"4.5.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,4,14]],"date-time":"2027-04-14T00:00:00Z","timestamp":1807660800000},"content-version":"am","delay-in-days":378,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA229803"],"award-info":[{"award-number":["R01CA229803"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["T32 CA254888"],"award-info":[{"award-number":["T32 CA254888"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018071","name":"Oregon Health & Science University Knight Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014547","name":"Parker Institute for Cancer Immunotherapy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006668","name":"Oregon Health and Science University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006668","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.immuni.2026.03.011","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T14:47:33Z","timestamp":1775141253000},"page":"1058-1074.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Agonistic anti-CD40 antibody treatment converts resident regulatory T cells into activated type 1 effectors within the tumor microenvironment"],"prefix":"10.1016","volume":"59","author":[{"given":"Vivien I.","family":"Maltez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charu","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle P.","family":"Gribbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Breanna","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret E.","family":"Haerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Sor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoshi","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie E.","family":"Blise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamilene","family":"Sivagnanam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalie C.","family":"Sears","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Coussens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Vonderheide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald N.","family":"Germain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2459-9041","authenticated-orcid":false,"given":"Katelyn T.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2026.03.011_bib1","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2026.03.011_bib2","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adg0539","article-title":"PD-1 blockade increases the self-renewal of stem-like CD8 T cells to compensate for their accelerated differentiation into effectors","volume":"8","author":"Gill","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.immuni.2026.03.011_bib3","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1084\/jem.20112741","article-title":"Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2","volume":"209","author":"Yokosuka","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.03.011_bib4","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20231242","article-title":"TCR ligand potency differentially impacts PD-1 inhibitory effects on diverse signaling pathways","volume":"220","author":"Chan","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.03.011_bib5","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1084\/jem.20082492","article-title":"Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti\u2013CTLA-4 antibodies","volume":"206","author":"Peggs","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.03.011_bib6","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1084\/jem.20130579","article-title":"Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti\u2013CTLA-4 therapy against melanoma","volume":"210","author":"Simpson","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.03.011_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JCO.19.02105","article-title":"Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability\/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study","volume":"38","author":"Marabelle","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.immuni.2026.03.011_bib8","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/8426","article-title":"CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help","volume":"5","author":"French","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2026.03.011_bib9","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/10495","article-title":"CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy","volume":"5","author":"Diehl","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2026.03.011_bib10","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/10503","article-title":"Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40","volume":"5","author":"Sotomayor","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2026.03.011_bib11","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.immuni.2018.06.006","article-title":"Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy","volume":"49","author":"Li","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.03.011_bib12","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.celrep.2016.05.058","article-title":"CD40 Stimulation Obviates Innate Sensors and Drives T Cell Immunity in Cancer","volume":"15","author":"Byrne","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.immuni.2026.03.011_bib13","doi-asserted-by":"crossref","first-page":"8022","DOI":"10.1073\/pnas.1918971117","article-title":"Sufficiency of CD40 activation and immune checkpoint blockade for T cell priming and tumor immunity","volume":"117","author":"Morrison","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2026.03.011_bib14","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1158\/2326-6066.CIR-23-0873","article-title":"Machine learning links T-cell function and spatial localization to neoadjuvant immunotherapy and clinical outcome in pancreatic cancer","volume":"12","author":"Blise","year":"2024","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.immuni.2026.03.011_bib15","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1158\/1078-0432.CCR-21-1047","article-title":"Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer","volume":"27","author":"Byrne","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.immuni.2026.03.011_bib16","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/s41591-022-01829-9","article-title":"Sotigalimab and\/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial","volume":"28","author":"Padr\u00f3n","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2026.03.011_bib17","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1470-2045(24)00263-8","article-title":"Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b\/2 study","volume":"25","author":"Van Laethem","year":"2024","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.immuni.2026.03.011_bib18","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.ccell.2025.07.013","article-title":"Fc-optimized CD40 agonistic antibody elicits tertiary lymphoid structure formation and systemic antitumor immunity in metastatic cancer","volume":"43","author":"Osorio","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2026.03.011_bib19","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190673","article-title":"Type 1 conventional dendritic cells are systemically dysregulated early in pancreatic carcinogenesis","volume":"217","author":"Lin","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.03.011_bib20","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/ni1536","article-title":"CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation\u2013mediated apoptosis of effector CD4+ T cells","volume":"8","author":"Pandiyan","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2026.03.011_bib21","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.4049\/jimmunol.177.7.4376","article-title":"Blockade of CTLA-4 on CD4+CD25+ Regulatory T Cells Abrogates Their Function In Vivo","volume":"177","author":"Read","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2026.03.011_bib22","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/ni.3868","article-title":"Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor","volume":"18","author":"Maj","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2026.03.011_bib23","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri1457","article-title":"Ido expression by dendritic cells: tolerance and tryptophan catabolism","volume":"4","author":"Mellor","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2026.03.011_bib24","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.trecan.2022.06.008","article-title":"Therapeutic targeting of regulatory T cells in cancer","volume":"8","author":"Shan","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.immuni.2026.03.011_bib25","doi-asserted-by":"crossref","first-page":"6674","DOI":"10.1158\/1078-0432.CCR-07-5212","article-title":"Sunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma Patients","volume":"14","author":"Finke","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.immuni.2026.03.011_bib26","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00262-011-1106-3","article-title":"Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome","volume":"61","author":"Ge","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.immuni.2026.03.011_bib27","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41586-024-07121-9","article-title":"Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells","volume":"627","author":"Guan","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2026.03.011_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109080","article-title":"Lymphocyte Activation Gene 3 (LAG-3) Modulates the Ability of CD4 T-cells to Be Suppressed In Vivo","volume":"9","author":"Durham","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.immuni.2026.03.011_bib29","doi-asserted-by":"crossref","first-page":"eaah4569","DOI":"10.1126\/sciimmunol.aah4569","article-title":"LAG3 limits regulatory T cell proliferation and function in autoimmune diabetes","volume":"2","author":"Zhang","year":"2017","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.immuni.2026.03.011_bib30","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2026.03.011_bib31","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1073\/pnas.1621280114","article-title":"CCR8+FOXp3+ Treg cells as master drivers of immune regulation","volume":"114","author":"Barsheshet","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2026.03.011_bib32","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2011.03.018","article-title":"Interleukin-10 Signaling in Regulatory T Cells Is Required for Suppression of Th17 Cell-Mediated Inflammation","volume":"34","author":"Chaudhry","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.03.011_bib33","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.immuni.2016.01.013","article-title":"Interleukin-35 Limits Anti-Tumor Immunity","volume":"44","author":"Turnis","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.03.011_bib34","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41590-019-0346-9","article-title":"Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion","volume":"20","author":"Sawant","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2026.03.011_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-26352-2","article-title":"Regulatory T cells promote cancer immune-escape through integrin \u03b1v\u03b28-mediated TGF-\u03b2 activation","volume":"12","author":"Lain\u00e9","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2026.03.011_bib36","article-title":"Molecular basis and therapeutic implications of CD40\/CD40L immune checkpoint","volume":"219","author":"Tang","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.immuni.2026.03.011_bib37","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/ni.1774","article-title":"Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo","volume":"10","author":"Zhou","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2026.03.011_bib38","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.immuni.2012.07.011","article-title":"Histo-Cytometry: A Method for Highly Multiplex Quantitative Tissue Imaging Analysis Applied to Dendritic Cell Subset Microanatomy in Lymph Nodes","volume":"37","author":"Gerner","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.03.011_bib39","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.immuni.2011.12.012","article-title":"Plasticity of Foxp3+ T Cells Reflects Promiscuous Foxp3 Expression in Conventional T Cells but Not Reprogramming of Regulatory T Cells","volume":"36","author":"Miyao","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.03.011_bib40","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41586-020-2611-3","article-title":"cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity","volume":"584","author":"Ferris","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2026.03.011_bib41","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.immuni.2015.07.020","article-title":"Spatiotemporally Distinct Interactions with Dendritic Cell Subsets Facilitates CD4+ and CD8+ T Cell Activation to Localized Viral Infection","volume":"43","author":"Hor","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.03.011_bib42","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1002\/eji.201040482","article-title":"The in situ dynamics of dendritic cell interactions","volume":"40","author":"Kastenm\u00fcller","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.immuni.2026.03.011_bib43","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.1164206","article-title":"Batf3 Deficiency Reveals a Critical Role for CD8\u03b1+ Dendritic Cells in Cytotoxic T Cell Immunity","volume":"322","author":"Hildner","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.immuni.2026.03.011_bib44","doi-asserted-by":"crossref","first-page":"13806","DOI":"10.1073\/pnas.95.23.13806","article-title":"Inhibition of interferon \u03b3 induced interleukin 12 production: A potential mechanism for the anti-inflammatory activities of tumor necrosis factor","volume":"95","author":"Hodge-Dufour","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2026.03.011_bib45","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1084\/jem.183.1.147","article-title":"The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells","volume":"183","author":"Ma","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.03.011_bib46","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S1074-7613(00)80413-6","article-title":"IL-12-Deficient Mice Are Defective in IFN\u03b3 Production and Type 1 Cytokine Responses","volume":"4","author":"Magram","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.03.011_bib47","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1126\/science.8456300","article-title":"Multiple Defects of Immune Cell Function in Mice with Disrupted Interferon-\u03b3 Genes","volume":"259","author":"Dalton","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.immuni.2026.03.011_bib48","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.immuni.2009.10.001","article-title":"Decrease of Foxp3+ Treg Cell Number and Acquisition of Effector Cell Phenotype during Lethal Infection","volume":"31","author":"Oldenhove","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.03.011_bib49","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.immuni.2010.11.022","article-title":"Reprogrammed Foxp3+ Regulatory T Cells Provide Essential Help to Support Cross-presentation and CD8+ T Cell Priming in Naive Mice","volume":"33","author":"Sharma","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.03.011_bib50","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1126\/science.1191996","article-title":"Stability of the Regulatory T Cell Lineage in Vivo","volume":"329","author":"Rubtsov","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.immuni.2026.03.011_bib51","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.pharmthera.2005.05.002","article-title":"FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors","volume":"108","author":"Chiba","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.immuni.2026.03.011_bib52","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.4049\/jimmunol.0904028","article-title":"Expression of Helios, an Ikaros Transcription Factor Family Member, Differentiates Thymic-Derived from Peripherally Induced Foxp3+ T Regulatory Cells","volume":"184","author":"Thornton","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2026.03.011_bib53","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/eji.201847935","article-title":"Helios+ and Helios- Treg subpopulations are phenotypically and functionally distinct and express dissimilar TCR repertoires","volume":"49","author":"Thornton","year":"2019","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.immuni.2026.03.011_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adg1487","article-title":"Lung tumor\u2013infiltrating Treg have divergent transcriptional profiles and function linked to checkpoint blockade response","volume":"8","author":"Dykema","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.immuni.2026.03.011_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms2260","article-title":"T-bet and GATA3 orchestrate Th1 and Th2 differentiation through lineage-specific targeting of distal regulatory elements","volume":"3","author":"Kanhere","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2026.03.011_bib56","doi-asserted-by":"crossref","first-page":"18169","DOI":"10.1073\/pnas.0703642104","article-title":"Antagonistic nature of T helper 1\/2 developmental programs in opposing peripheral induction of Foxp3+ regulatory T cells","volume":"104","author":"Wei","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2026.03.011_bib57","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.immuni.2009.09.002","article-title":"Cross-regulation of Signaling Pathways by Interferon-\u03b3: Implications for Immune Responses and Autoimmune Diseases","volume":"31","author":"Hu","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.03.011_bib58","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1074-7613(00)80025-4","article-title":"Stat5 Is Required for IL-2-Induced Cell Cycle Progression of Peripheral T Cells","volume":"10","author":"Moriggl","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.03.011_bib59","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/ni794","article-title":"T-bet is a STAT1-induced regulator of IL-12R expression in na\u00efve CD4+ T cells","volume":"3","author":"Afkarian","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2026.03.011_bib60","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.immuni.2017.05.005","article-title":"The Transcription Factor T-bet Limits Amplification of Type I IFN Transcriptome and Circuitry in T Helper 1 Cells","volume":"46","author":"Iwata","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.03.011_bib61","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.celrep.2019.01.070","article-title":"Blimp1 Prevents Methylation of Foxp3 and Loss of Regulatory T Cell Identity at Sites of Inflammation","volume":"26","author":"Garg","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.immuni.2026.03.011_bib62","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/s41590-021-00987-1","article-title":"TCF-1 controls Treg cell functions that regulate inflammation, CD8+ T cell cytotoxicity and severity of colon cancer","volume":"22","author":"Osman","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2026.03.011_bib63","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.humimm.2011.05.020","article-title":"CD4+CD25+Foxp3+IFN-\u03b3+ human induced T regulatory cells are induced by interferon-\u03b3 and suppress alloresponses nonspecifically","volume":"72","author":"Daniel","year":"2011","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.immuni.2026.03.011_bib64","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41586-019-1215-2","article-title":"Targeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy","volume":"570","author":"Di Pilato","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2026.03.011_bib65","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/ni.1731","article-title":"The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation","volume":"10","author":"Koch","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2026.03.011_bib66","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/35074122","article-title":"IFN\u03b3 and lymphocytes prevent primary tumour development and shape tumour immunogenicity","volume":"410","author":"Shankaran","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2026.03.011_bib67","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.immuni.2012.11.012","article-title":"Peripheral Prepositioning and Local CXCL9 Chemokine-Mediated Guidance Orchestrate Rapid Memory CD8+ T Cell Responses in the Lymph Node","volume":"38","author":"Kastenm\u00fcller","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.03.011_bib68","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.immuni.2023.06.003","article-title":"CXCR3 expression in regulatory T cells drives interactions with type I dendritic cells in tumors to restrict CD8+ T cell antitumor immunity","volume":"56","author":"Moreno Ayala","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.03.011_bib69","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ccell.2017.04.003","article-title":"Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy","volume":"31","author":"Spranger","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2026.03.011_bib70","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.immuni.2019.04.010","article-title":"Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy","volume":"50","author":"Chow","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.03.011_bib71","article-title":"CXCL9\/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer","volume":"5","author":"Lim","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.immuni.2026.03.011_bib72","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nri1632","article-title":"NFAT proteins: key regulators of T-cell development and function","volume":"5","author":"Macian","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2026.03.011_bib73","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1016\/j.cell.2021.05.027","article-title":"Expansion of tumor-associated Treg cells upon disruption of a CTLA-4-dependent feedback loop","volume":"184","author":"Marangoni","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2026.03.011_bib74","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1172\/JCI67233","article-title":"2-photon imaging of phagocyte-mediated T cell activation in the CNS","volume":"123","author":"Pesic","year":"2013","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.immuni.2026.03.011_bib75","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.immuni.2012.09.012","article-title":"The Transcription Factor NFAT Exhibits Signal Memory during Serial T Cell Interactions with Antigen-Presenting Cells","volume":"38","author":"Marangoni","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.03.011_bib76","doi-asserted-by":"crossref","first-page":"33455","DOI":"10.1073\/pnas.2018488117","article-title":"IBEX: A versatile multiplex optical imaging approach for deep phenotyping and spatial analysis of cells in complex tissues","volume":"117","author":"Radtke","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2026.03.011_bib77","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s43018-024-00881-3","article-title":"Ongoing replication stress tolerance and clonal T cell responses distinguish liver an dlung recurrence and outcomes in pancreatic cancer","volume":"6","author":"Link","year":"2025","journal-title":"Nature Cancer"},{"key":"10.1016\/j.immuni.2026.03.011_bib78","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/ni.1790","article-title":"Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR\u2013induced stop signal","volume":"10","author":"Fife","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2026.03.011_bib79","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1084\/jem.20050783","article-title":"Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo","volume":"203","author":"Tadokoro","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.03.011_bib80","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1073\/pnas.0811556106","article-title":"Heterogeneity of natural Foxp3+ T cells: A committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity","volume":"106","author":"Komatsu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2026.03.011_bib81","doi-asserted-by":"crossref","first-page":"22699","DOI":"10.1073\/pnas.1821218116","article-title":"Combination anti-CTLA-4 plus anti-PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies","volume":"116","author":"Wei","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2026.03.011_bib82","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41590-019-0555-2","article-title":"An intrinsic role of IL-33 in Treg cell\u2013mediated tumor immunoevasion","volume":"21","author":"Hatzioannou","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2026.03.011_bib83","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.cell.2017.05.005","article-title":"Interferon-\u03b3 Drives Treg Fragility to Promote Anti-tumor Immunity","volume":"169","author":"Overacre-Delgoffe","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2026.03.011_bib90","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1158\/2159-8290.CD-20-0841","article-title":"Leukocyte Heterogeneity in Pancreatic Ductal Adenocarcinoma: Phenotypic and Spatial Features Associated with Clinical Outcome","volume":"11","author":"Liudahl","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.immuni.2026.03.011_bib92","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2006-7-10-r100","article-title":"CellProfiler: image analysis software for identifying and quantifying cell phenotypes","volume":"7","author":"Carpenter","year":"2006","journal-title":"Genome Biol."},{"key":"10.1016\/j.immuni.2026.03.011_bib84","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/1074-7613(94)90095-7","article-title":"The immune responses in CD40-deficient mice: Impaired immunoglobulin class switching and germinal center formation","volume":"1","author":"Kawabe","year":"1994","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.03.011_bib85","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1126\/science.8456301","article-title":"Immune Response in Mice that Lack the Interferon-\u03b3 Receptor","volume":"259","author":"Huang","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.immuni.2026.03.011_bib86","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1074-7613(02)00365-5","article-title":"In Vivo Depletion of CD11c+ Dendritic Cells Abrogates Priming of CD8+ T Cells by Exogenous Cell-Associated Antigens","volume":"17","author":"Jung","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.03.011_bib87","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1158\/2326-6066.CIR-13-0152","article-title":"Role of Crosslinking for Agonistic CD40 Monoclonal Antibodies as Immune Therapy of Cancer","volume":"2","author":"Richman","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.immuni.2026.03.011_bib88","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1158\/2326-6066.CIR-14-0215","article-title":"Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma","volume":"3","author":"Winograd","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.immuni.2026.03.011_bib89","doi-asserted-by":"crossref","DOI":"10.3791\/60497","article-title":"Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma","author":"Hay","year":"2019","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.immuni.2026.03.011_bib91","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev-med-062518-045435","article-title":"CD40 Agonist Antibodies in Cancer Immunotherapy","volume":"71","author":"Vonderheide","year":"2019","journal-title":"Annu. Rev. Med."}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761326001226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761326001226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:07:21Z","timestamp":1777608441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761326001226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":92,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1074761326001226"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2026.03.011","relation":{},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Agonistic anti-CD40 antibody treatment converts resident regulatory T cells into activated type 1 effectors within the tumor microenvironment","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2026.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}